A Research Study Looking Into Blood and Urine Levels of the Medicine NNC0194-0499 in the Body and How Well it is Tolerated in Participants With Reduced Kidney Function and Normal Kidney Function
PHASE1
Novo Nordisk is developing the study medicine NNC0194-0499 for the treatmen...
A Research Study Looking at How a Single Dose of the Study Medicine NNC0194-0499 Behaves in Participants With Reduced Liver Function Compared to Participants With Normal Liver Function
PHASE1
The study medicine NNC0194-0499 is under development for non-alcoholic fatt...
Effects of NNC0194-0499, Cagrilintide, and Semaglutide Alone or in Combinations on Liver Damage and Alcohol Use in People With Alcohol-related Liver Disease
PHASE2
The study will look at the effects of NNC0194-0499, cagrilintide and semagl...